Lack of Adverse Events after Medialization Laryngoplasty with the Montgomery Thyroplasty Implant in Patients with Unilateral Laryngeal Nerve Paralysis

Laccourreye, O.; Benkhatar, Hakim; Ménard, M.

doi:10.1177/000348941212101101

Cited by 20 publications

(26 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The reported complication rate for patients undergoing type 1 thyroplasty is between 7% and 20%. 12,13,15,17,18,[19][20][21][22] However, our study found a major complication rate of 5.6% with no long-term morbidity or mortalities. There were 4 cases of airway complications that were considered major; however, none of the patients required intubation or tracheostomy.…”

Section: Discussionmentioning

confidence: 74%

Safety of Outpatient Type 1 Thyroplasty

et al. 2020

View full text Add to dashboard Cite

Objective: Type 1 thyroplasty is an established procedure for the treatment of vocal fold paralysis to improve voice and swallowing outcomes. At our institution, we commonly perform this procedure on an outpatient basis in medically stable patients. With this study, we assess the safety of outpatient thyroplasty by examining complication and readmission rates, need for revision surgery, and predictors of these outcome measures. Methods: We performed a retrospective review of patients undergoing outpatient type 1 thyroplasty for vocal fold paralysis between 2013 and 2018 at our institution. We documented the etiology of paralysis, comorbidities, and demographic data. Our primary outcome measures were complications, need for readmission, and need for revision surgery. Results: During the study period, 160 patients met our inclusion criteria. Mean age at time of surgery was 62.1 ± 13.9 years; there were 82 (51%) males and 78 (49%) females. Nine (5.6%) patients experienced major complications after surgery and 7 (4.4%) patients required unplanned readmission. Mean time to complication was 6.9 ± 9.7 days. There were no instances of postoperative airway compromise requiring intervention. There were no mortalities. Of those who underwent primary surgery, 22 (14%) patients required revision surgery. Conclusion: Given that complications tend to occur in a delayed fashion rather than in the acute postoperative period, same-day discharge seems reasonable as compared to overnight observation in medically stable patients undergoing type 1 thyroplasty. Level of Evidence: IV

show abstract

Section: Discussionmentioning

confidence: 74%

Safety of Outpatient Type 1 Thyroplasty

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Permanent recurrent laryngeal nerve injury may occur after surgery for thyroid cancer or thyroid nodular goiter and may require laryngeal surgery [ 24 ]. Thyroplasty is typically the first choice to treat permanent UVFP and stable results have been presented in the literature [ 25 ]. However, foreign body reaction and migration of implants may appear in long-term follow-up.…”

Section: Discussionmentioning

confidence: 99%

Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis

Tsou

Liu

Chang

et al. 2016

BioMed Research International

View full text Add to dashboard Cite

Objective. Autologous fat injection laryngoplasty is ineffective for some patients with iatrogenic vocal fold paralysis, and additional laryngeal framework surgery is often required. An acoustically measurable outcome predictor for lipoinjection laryngoplasty would assist phonosurgeons in formulating treatment strategies. Methods. Seventeen thyroid surgery patients with unilateral vocal fold paralysis participated in this study. All subjects underwent lipoinjection laryngoplasty to treat postsurgery vocal hoarseness. After treatment, patients were assigned to success and failure groups on the basis of voice improvement. Linear prediction analysis was used to construct a new voice quality indicator, the number of irregular peaks (NIrrP). It compared with the measures used in the Multi-Dimensional Voice Program (MDVP), such as jitter (frequency perturbation) and shimmer (perturbation of amplitude). Results. By comparing the [i] vowel produced by patients before the lipoinjection laryngoplasty (AUC = 0.98, 95% CI = 0.78–0.99), NIrrP was shown to be a more accurate predictor of long-term surgical outcomes than jitter (AUC = 0.73, 95% CI = 0.47–0.91) and shimmer (AUC = 0.63, 95% CI = 0.37–0.85), as identified by the receiver operating characteristic curve. Conclusions. NIrrP measured using the LP model could be a more accurate outcome predictor than the parameters used in the MDVP.

show abstract

“…Several previous studies have demonstrated the many postoperative benefits of MT, including improvements in voice quality, swallowing impairments, and breathlessness. [4][5][6] MT can be performed with different implant materials (eg, thyroid cartilage, silastic, goretex Ò , titanium, hydroxylapatite, or different injectables), with all different advantages and disadvantages. For the latter, we refer to the literature.…”

Section: Introductionmentioning

confidence: 99%

Surgical Impact of the Montgomery Implant System on Arytenoid Cartilage and the Paralyzed Vocal Fold

et al. 2020

View full text Add to dashboard Cite

Lack of Adverse Events after Medialization Laryngoplasty with the Montgomery Thyroplasty Implant in Patients with Unilateral Laryngeal Nerve Paralysis

Abstract: Our data demonstrate that medialization laryngoplasty with Montgomery implant insertion in patients with unilateral laryngeal nerve paralysis from various causes is a relatively safe, reliable, and reproducible procedure with a short learning curve.

Cited by 20 publications

References 27 publications

Safety of Outpatient Type 1 Thyroplasty

Safety of Outpatient Type 1 Thyroplasty

Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis

Surgical Impact of the Montgomery Implant System on Arytenoid Cartilage and the Paralyzed Vocal Fold

Contact Info

Product

Resources

About